NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/05/2023
Back to search
Official data from USPTO
AFFISORB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFFISORB
ST13
US500000079027965Class
1, 5, 10, 42
Filing
79027965
Registration
3602579
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
08/05/2023
Trademark type
Word
Nice classes
1, 5, 10, 42
Filing date
06/08/2006
Registration date
04/07/2009
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/13/2015
Last transaction
03/16/2016
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
BLANE, SUZANNE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AC Immune SA
Affiris AG
Affiris Forschungs- und Entwicklungs GmbH
Representatives
JULIE B. SEYLER ABELMAN, FRAYNE & SCHWAB
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for use in medical researchscience and laboratories; biological preparations in the nature of molecules for use in medical researchscience and laboratories for purposes of researchanalysis and diagnosticsbiological reagents known as probes for detecting and analyzing molecules in proteins or nucleotide arrays
Class 5
Pharmaceutical preparations designed to remove pathological molecules from the blood for therapy and prophylaxis of medical conditionsAlzheimer disease and arteriosclerosis and other cardio-vascular diseases; chemical preparations for pharmaceutical and medical purposespeptide based substances for use in the treatment of Alzheimer disease and arteriosclerosis and other cardio-vascular diseases; vaccinesdiagnostic preparations for medical purposeschemical reagents for medical and veterinary purposesfor treatment and diagnosis of Alzheimer disease and arteriosclerosis and other cardio-vascular diseases; chemical and biological substances for medical usefor Alzheimer disease and arteriosclerosis and other cardio-vascular diseases
Class 10
Medical instruments and apparatus as well as replacement parts of the aforementioned goodsinstruments and apparatus used in blood analysis and for removing pathological molecules from the blood for use in therapy and prophylaxis of medical conditionsblood filtersblood component separation apparatus
Class 42
Development of medical diagnostictherapy and test methodsconducing clinical trials and scientific investigations for medical purposesresearch in the field of chemical medicinepharmaceutics and bacteriology
Publications
History of USPTO decisions and trademark events.
51 publications found
CHLD
CHANGE OF OWNER RECEIVED FROM IB
02/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/01/2021
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
04/21/2017
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/15/2016
INPC
INVALIDATION PROCESSED
07/15/2016
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
07/13/2016
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/23/2016
C71T
CANCELLED SECTION 71
11/13/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/11/2013
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/04/2011
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/22/2009
FIMP
FINAL DISPOSITION PROCESSED
07/22/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
04/07/2009
PUBO
PUBLISHED FOR OPPOSITION
01/20/2009
NPUB
NOTICE OF PUBLICATION
12/31/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/16/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/10/2008
CNRT
NON-FINAL ACTION MAILED
07/17/2008
CNRT
NON-FINAL ACTION WRITTEN
07/16/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2008
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/28/2008
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/13/2008
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/13/2008
CNRT
NON-FINAL ACTION MAILED
01/22/2008
CNRT
NON-FINAL ACTION WRITTEN
01/19/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2007
CPRA
PRIORITY ACTION MAILED
06/22/2007
CPRA
PRIORITY ACTION WRITTEN
06/21/2007
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/01/2007
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/30/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/30/2007
ALIE
ASSIGNED TO LIE
05/30/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2007
PAPER RECEIVED
05/11/2007
RFNT
REFUSAL PROCESSED BY IB
12/08/2006
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/16/2006
RFRR
REFUSAL PROCESSED BY MPU
11/16/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/16/2006
CNRT
NON-FINAL ACTION WRITTEN
11/15/2006
DOCK
ASSIGNED TO EXAMINER
11/08/2006
NWAP
NEW APPLICATION ENTERED
10/13/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/12/2006
Continuous trademark protection
Get notified about every new filing that threatens AFFISORB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.